Drug Channels

APRIL 27, 2025

Spring has officially arrived at Drug Channels' worldwide headquarters in beautiful downtown Philadelphia. (Photo proof at right.) So, scurry over to this months curated crop of noteworthy news: Amazon Pharmacy is still coming for retail pharmacy Express Scripts revives its long-lost drug trend report Prior authorization gold cards: Progress or peril?

Pharmacy

Drugs.com

APRIL 27, 2025

SUNDAY, April 27, 2025 One moment, Dr. Cornelius Sullivan was standing over a patient during surgery. The next, he woke up in an ambulance on the way to the emergency room.The anesthesiologist had hit his head on a monitor that had been moved b.

FDA Law Blog: Biosimilars

APRIL 27, 2025

By Hyman, Phelps & McNamara, P.C. As a reminder, Hyman, Phelps & McNamara, P.C. is hosting a free webinar on recent and forward-looking enforcement under the Federal Food, Drug & Cosmetic Act on Thursday, May 1, 2025, from 12:00 p.m. to 1:30 p.m. (ET). Registration is limited, so dont forget to register here to join us this Thursday. HPMs Anne Walsh will moderate a panel discussion with three former DOJ attorneys who all litigated extensively under the FDC Act.

FDA

Covalent Modifiers

APRIL 27, 2025

R. Justin Grams, Wesley J. Wolfe, Robert J. Seal, James Veccia, and Ku-Lung Hsu Journal of Medicinal Chemistry 2025 DOI: 10.1021/acs.jmedchem.5c00050 Aldo-keto reductase family 1 member C3 (AKR1C3) is a member of the AKR superfamily of enzymes that metabolize androgen, estrogen, and prostaglandin substrates that drive proliferation in hormone-dependent cancers.

Cell Biology

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

New Drug Approvals

APRIL 27, 2025

Trospium chloride CAS 47608-32-2 10405-02-4 WeightAverage: 392.518 Monoisotopic: 392.22202025 Chemical FormulaC 25 H 30 NO 3 T4Y8ORK057 73954-17-3 8-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride 3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-8lambda5-azaspiro[bicyclo[3.2.1]octane-8,1′-pyrrolidin]-8-yliumchloride spiro[8-azoniabicyclo[3.2.1]octane-8,1′-azolidin-1-ium]-3-yl 2-hydroxy-2,2-diphenylacetate;chloride SMR002533165 spiro[8-azoniabicyclo[3.2.1]octane-8,1′-azolidin-1-

FDA Approval

Perficient: Drug Development

APRIL 27, 2025

When it comes to cycle counting, the first thing that comes to mind is ABC classifications of the items and then a cycle count program to count items throughout the year on a continuous basis. There is nothing wrong with the ABC classifications if the organization is mature enough with its items and the classification criteria is going to be somewhat stable during the year.